Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma

AIM: To investigate the clinicopathological significance of progesterone receptor membrane component 1 (PGRMC1) and PGRMC2 in hepatocellular carcinoma (HCC). METHODS: We performed immunohistochemical staining to evaluate the estrogen receptor (ER), progesterone receptor (PR), PGRMC1, and PGRMC2 in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hung-Wen, Ho, Chung-Liang, Cheng, Shu-Wen, Lin, Yih-Jyh, Chen, Chou-Cheng, Cheng, Pin-Nan, Yen, Chia-Jui, Chang, Ting-Tsung, Chiang, Po-Min, Chan, Shih-Huang, Ho, Cheng-Hsun, Chen, Shu-Hui, Wang, Yi-Wen, Chow, Nan-Haw, Lin, Jou-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Clinical Practice Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850134/
https://www.ncbi.nlm.nih.gov/pubmed/29563759
http://dx.doi.org/10.3748/wjg.v24.i10.1152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850134/
https://www.ncbi.nlm.nih.gov/pubmed/29563759
http://dx.doi.org/10.3748/wjg.v24.i10.1152

Ejemplares similares